Full access
New Research
Published Online: 1 December 2012

Up-Regulation of NOTCH4 Gene Expression in Bipolar Disorder

Ingrid Dieset, M.D., Srdjan Djurovic, Ph.D., Martin Tesli, M.D., Sigrun Hope, M.D., Morten Mattingsdal, Ph.D., Annika Michelsen, Ph.D., Inge Joa, Ph.D., … Show All … , Tor Ketil Larsen, M.D., Ph.D., Ingrid Agartz, M.D., Ph.D., Ingrid Melle, M.D., Ph.D., Jan Ivar Røssberg, M.D., Ph.D., Pål Aukrust, M.D., Ph.D., Ole A. Andreassen, M.D., Ph.D., and Thor Ueland, Ph.D.Authors Info & Affiliations
Publication: American Journal of Psychiatry
Volume 169, Number 12
https://doi.org/10.1176/appi.ajp.2012.11091431
Track CitationsAdd to favorites
PDF/EPUBformats

Abstract

Objective

Immunopathogenic mechanisms have been implicated in schizophrenia and bipolar disorder, and genome-wide association studies (GWAS) point to the major histocompatibility complex, a region that contains many immune-related genes. One of the strongest candidate risk genes for schizophrenia and bipolar disorder is the NOTCH4 gene within the major histocompatibility complex. The authors investigated the NOTCH4 gene expression in individuals with bipolar disorder and schizophrenia relative to healthy comparison subjects and identified putative expression quantitative trait loci in and around the NOTCH4 gene.

Method

The authors measured and compared NOTCH4 mRNA in whole blood in 690 individuals (479 patients and 211 healthy comparison subjects) and adjusted for a range of confounders. The authors also genotyped 20 single-nucleotide polymorphisms (SNPs) and investigated possible associations between expression quantitative trait loci and NOTCH4 expression.

Results

The authors found a strong association between NOTCH4 expression and bipolar disorder after adjusting for a range of confounders and multiple testing. In addition, seven SNPs within the NOTCH4 gene region were associated with enhanced NOTCH4 mRNA levels. Three of these expression quantitative trait loci were independent (not in linkage disequilibrium).

Conclusions

The results indicate that the association between NOTCH4 DNA markers and bipolar disorder is related to altered function at the mRNA level, supporting the notion that NOTCH4 pathways are involved in the pathophysiology of bipolar disorder.

Formats available

You can view the full content in the following formats:

View PDF/ePubView Full Text

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Volume 169 • Number 12 • December 2012
Pages: 1292 - 1300
PubMed: 23212060

History

Received: 26 September 2011
Revision received: 5 March 2012
Revision received: 21 April 2012
Revision received: 1 June 2012
Accepted: 20 July 2012
Published online: 1 December 2012
Published in print: December 2012

Authors

Details

Ingrid Dieset, M.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Srdjan Djurovic, Ph.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Martin Tesli, M.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Sigrun Hope, M.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Morten Mattingsdal, Ph.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Annika Michelsen, Ph.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Inge Joa, Ph.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Tor Ketil Larsen, M.D., Ph.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Ingrid Agartz, M.D., Ph.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Ingrid Melle, M.D., Ph.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Jan Ivar Røssberg, M.D., Ph.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Pål Aukrust, M.D., Ph.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Ole A. Andreassen, M.D., Ph.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author
Thor Ueland, Ph.D.
From the Division of Mental Health and Addiction, Oslo University Hospital Ullevål, Oslo, Norway; KG Jebsen Center for Psychosis Research, the Institute of Clinical Medicine, University of Oslo, Oslo; the Department of Psychiatry, Østfold Hospital, Fredrikstad, Norway; the Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo; the Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo; the Faculty of Medicine, University of Oslo, Oslo; the Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Norway; the Department of Medical Genetics, Oslo University Hospital Ullevål, Oslo; Stavanger University Hospital, Division of Psychiatry, Regional Center for Clinical Psychosis Research, Stavanger, Norway; the Department of Clinical Medicine, Section Psychiatry, University of Bergen, Norway; and Sørlandet Hospital HF, Kristiansand, Norway.
View all articles by this author

Notes

Address correspondence to Dr. Dieset ([email protected]).

Funding Information

Dr. Dieset has received a research award from Lundbeck. Drs. Dieset, Hope, and Tesli have received travel expenses from Astra Zeneca for a Scandinavian College of Neuropsychopharmacology research conference. Dr. Melle and Dr. Andreassen have received speaker’s honorarium from Janssen and AstraZeneca, and Dr. Andreassen has also received speaker’s honorarium from Bristol-Myers Squibb and GlaxoSmithKline. The other authors report no financial relationships with commercial interests.
Supplementary Material
Supported by the Research Council of Norway (grants 167153/V50, 163070/V50, 175345/V50), South-Eastern and Western Norway Health Authority (123-2004), and Oslo University Hospital Ullevål and the University of Oslo for the Thematic Organized Psychosis Research Study group.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Item saved, go to cart
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.